FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases

by Erik J. Tillman, Tim Rolph
Published 2020-12-01

AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients

by Allegra Kaufman, Lubna Abuqayyas, William S. Denney, Erik J. Tillman, Tim Rolph
Published 2020-07-01

Three months of high-fructose feeding fails to induce excessive weight gain or leptin resistance in mice.

by Erik J Tillman, Donald A Morgan, Kamal Rahmouni, Steven J Swoap
Published 2014-01-01

Global transcriptional regulation of innate immunity by ATF-7 in C. elegans.

by Marissa Fletcher, Erik J Tillman, Vincent L Butty, Stuart S Levine, Dennis H Kim
Published 2019-02-01

De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling.

by Catherine A Del Vecchio, Yuxiong Feng, Ethan S Sokol, Erik J Tillman, Sandhya Sanduja, Ferenc Reinhardt, Piyush B Gupta
Published 2014-09-01